Malignant Mesothelioma Pipeline Landscape Analysis, 2024 - Incyte's INCB001158 and Polaris' Pegargiminase Lead the Way in Mechanism-Specific Interventions
June 07, 2024 09:19 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Malignant Mesothelioma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been...
Malignant Mesothelioma Competitive Landscape Report 2021: 178 Drugs in the Pipeline with 84% Molecules Present in Early Stage Development
June 21, 2021 07:38 ET
|
Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Malignant Mesothelioma - Competitive Landscape in 2021" report has been added to ResearchAndMarkets.com's offering. This reports provides a data-driven...